National Plan to End Parkinson's Act This bill requires the Department of Health and Human Services (HHS) to carry out a project to prevent and cure Parkinson's disease (a progressive brain disorder that causes unintended or uncontrollable movements) and related conditions. Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent, slow the progression of, and cure the disease; and (2) improve diagnosis, treatment, and care of those with the disease. HHS must also annually assess the preparations for and response to the increased burden of Parkinson's disease. In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and treatment of Parkinson's disease. The provisions of the bill terminate at the end of calendar year 2035.
VOTE BREAKDOWN
Final passage · 362 politicians tracked
342
YEA
7
NAY
0
PRESENT
13
NOT VOTING
BY PARTY · ✕ NAY ← | → YEA ✓
MONEY ON THIS BILL
Which donor industries fund each side of the vote — total contributions from that industry to those members, all cycles · plus lobbying activity in affected industries
⬆ YEA voters — top donor industries
⬇ NAY voters — top donor industries
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
Dollar figures are each industry's total contributions to those members across all tracked cycles — not money given for this specific bill. Statistical patterns in public records; correlation, not causation.
LOBBYING ON THIS BILL
36 federal lobbying reports name this bill in their activity descriptions · LDA disclosures
⟳ The revolving door — lobbyists on this bill with disclosed former government roles
“Covered position” is the former government job lobbyists must disclose by law (LDA §4). Prior service is stated on the filings; it carries no implication of wrongdoing. Full revolving-door board →
A report naming a bill means the organization disclosed lobbying activity on it — the disclosure does not state a position for or against.
INDIVIDUAL VOTES
Recorded positions for tracked politicians






















































































































































































































































































































































SPONSORS

Gus M. Bilirakis
R-FL · Primary
139 COSPONSORS
BIPARTISANSPONSOR FUNDING
Top industries funding Bilirakis
TRAIL AI
HR 2365, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act, establishes a comprehensive national strategy to address Parkinson's disease research, care, and services. The bill passed with strong bipartisan support, receiving 342 votes in favor and 7 opposed, with all Democratic votes in support and 7 Republican votes against. The legislation has been signed into law.
Based on public voting records. Does not imply causation.
TIMELINE
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.